Dojindo Molecular Technologies
Plan context: Dojindo Molecular Technologies Inc 401(K) Plan
EIN 52-1999733 • Rockville, MD • 3 filings • 1 plans
Current Snapshot
Latest Year
2011
2011 Participants
1
2011 Assets
$2,923
2011 Contributions
$807
Historical Graphs
Total Assets Over Time
Aggregate end-of-year assets by filing year, excluding zero-asset years
Participants Over Time
Largest reported end-of-year plan headcount by filing year, used to avoid double-counting participants across overlapping plans
Company Timeline
Year summaries and individual filings are combined here so you can stay in one place while moving across years and plan filings.
| Year / Filing | Filings | Participants | Assets | Contributions | Contrib./Participant |
|---|---|---|---|---|---|
| 2011 | 1 | 0 | $0 | $807 | - |
| Dojindo Molecular Technologies Inc 401(K) Plan | - | 0 | $0 | $807 | - |
| 2010 | 1 | 1 | $2,923 | $1,787 | $1,787iApproximate average salary by contribution assumption: employee only about $44,675 at 4% or $29,783 at 6%; with 50% employer match about $29,783 at 4% or $19,856 at 6%; with 100% employer match about $22,338 at 4% or $14,892 at 6%. |
| Dojindo Molecular Technologies Inc 401(K) Plan | - | 1 | $2,923 | $1,787 | $1,787iApproximate average salary by contribution assumption: employee only about $44,675 at 4% or $29,783 at 6%; with 50% employer match about $29,783 at 4% or $19,856 at 6%; with 100% employer match about $22,338 at 4% or $14,892 at 6%. |
| 2009 | 1 | 9 | $6,191 | $4,970 | $552iApproximate average salary by contribution assumption: employee only about $13,806 at 4% or $9,204 at 6%; with 50% employer match about $9,204 at 4% or $6,136 at 6%; with 100% employer match about $6,903 at 4% or $4,602 at 6%. |
| Dojindo Molecular Technologies Inc 401(K) Plan | - | 9 | $6,191 | $4,970 | $552iApproximate average salary by contribution assumption: employee only about $13,806 at 4% or $9,204 at 6%; with 50% employer match about $9,204 at 4% or $6,136 at 6%; with 100% employer match about $6,903 at 4% or $4,602 at 6%. |